ArticleObstetrics and gynecology2026
Sleep Disruption in the Menopausal Transition and Postmenopause: A Narrative Review.
Article in Obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The objective of this narrative review is to provide a comprehensive overview of sleep disruptions during menopause by examining primary sleep disorders and secondary disruptors, the biopsychosocial etiology of these disruptions, and approaches to clinical diagnosis. Literature published between January 2015 and March 2026 was searched using PubMed and MEDLINE, Embase, and Google Scholar databases. Findings are summarized into a narrative review that addresses primary sleep disorders that commonly occur during menopause, specifically insomnia, obstructive sleep apnea, restless legs syndrome, and periodic limb movement disorder, as well as the biopsychosocial etiology of sleep pathophysiology. Prevalence of sleep disruption varies by menopausal stage (perimenopause or postmenopause), the presence of vasomotor symptoms, and the definition and measurement of sleep disruptions (self-report questionnaires or objective measures), and can be influenced by a variety of modifiable and nonmodifiable factors. Compared with premenopausal women, prevalence is higher in women during perimenopause and postmenopause, highlighting an increased burden and effect on quality of life in this population. Individual biological, psychological, and social disruptors and their contributions to and effects on sleep are described, as well as practical clinical considerations in the assessment of sleep disruption symptoms. Finally, salient points are discussed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.